Infection Surveillance Module Adds Business Intelligence Reporting - Antimicrobial Stewardship Programs (ASPs).

As the article mentions below, ASP software is becoming a priority for hospitals and all hospitals in California have been asked to install the software so both bugs and their therapies can be traced through the hospital system. The other alternative is manual search . Asolva is one company that licenses and sells such software that will integrate with EHR systems.

The software is the tool for the hospital pharmacist and they recommend using with a tablet for ease of access and data entry in the hospital so the pharmacist can be mobile when needed. When the pharmacist comes on duty, the work flow is created with patients that needs to be watched with labs and medications. They can also see the trending of patient medications and tract antibiotic actions and performance by patient as well as activity from pharmacists from the last shift. BD

LOS ANGELES, May 17 /PRNewswire/ -- Asolva (www.asolva.com), a leading provider of healthcare data analytics and reporting systems, has added a package of infection surveillance tools to Medici, its clinical information management system. The package will assist pharmacists, physicians and other infection preventionists in tracking and maximizing their antimicrobial stewardship programs (ASPs).

The new module automatically monitors key data points across a hospital's entire information system, including patient records, lab and microbiology results, and medication records. It can identify pharmaceutical intervention opportunities for clinicians, and provide comprehensive reporting on the usage of antimicrobials throughout the hospital in-patient population.

The software enables better antimicrobial stewardship programs (ASPs) by monitoring appropriate drug-bug therapies and potentially inappropriate utilization of antimicrobials within susceptible patient populations. It also facilitates patient hand-off and helps pharmacists and other infection preventionists provide appropriate therapies for key indicators such as creatinine/INR abnormalities, IV/PO use and duplicate medication therapy.

"ASPs are becoming a top priority for hospitals to manage costs and meet licensing and accreditation requirements. For example, the California Department of Public Health has asked all hospitals in the state to implement an ASP," said Chun Wong, chief executive officer of Asolva.